Robert Naclerio to Histamine Release
This is a "connection" page, showing publications Robert Naclerio has written about Histamine Release.
Connection Strength
1.756
-
Clinical manifestations of the release of histamine and other inflammatory mediators. J Allergy Clin Immunol. 1999 Mar; 103(3 Pt 2):S382-5.
Score: 0.165
-
Relationship between histamine and physiological changes during the early response to nasal antigen provocation. J Appl Physiol (1985). 1999 Feb; 86(2):659-68.
Score: 0.164
-
Bilateral increases in histamine after unilateral nasal allergen challenge. Am J Respir Crit Care Med. 1997 Feb; 155(2):426-31.
Score: 0.143
-
Origin of late phase histamine release. J Allergy Clin Immunol. 1996 Oct; 98(4):721-3.
Score: 0.139
-
Physiologic responses and histamine release after nasal antigen challenge. Effect of atropine. Am J Respir Crit Care Med. 1994 Jun; 149(6):1457-65.
Score: 0.118
-
Effects of antihistamines on inflammatory mediators. Ann Allergy. 1993 Sep; 71(3):292-5.
Score: 0.112
-
Steroid-induced reduction of histamine release does not alter the clinical nasal response to cold, dry air. Am Rev Respir Dis. 1991 Apr; 143(4 Pt 1):761-5.
Score: 0.095
-
Terfenadine, an H1 antihistamine, inhibits histamine release in vivo in the human. Am Rev Respir Dis. 1990 Jul; 142(1):167-71.
Score: 0.090
-
The osmolality of nasal secretions increases when inflammatory mediators are released in response to inhalation of cold, dry air. Am Rev Respir Dis. 1988 Mar; 137(3):625-9.
Score: 0.077
-
Nasal ocular reflexes and eye symptoms in patients with allergic rhinitis. Ann Allergy Asthma Immunol. 2008 Mar; 100(3):194-9.
Score: 0.077
-
Theophylline reduces histamine release during pollen-induced rhinitis. J Allergy Clin Immunol. 1986 Nov; 78(5 Pt 1):874-6.
Score: 0.070
-
Inflammatory mediators in late antigen-induced rhinitis. N Engl J Med. 1985 Jul 11; 313(2):65-70.
Score: 0.064
-
Effects of fexofenadine on the early response to nasal allergen challenge. Ann Allergy Asthma Immunol. 2002 Dec; 89(6):578-84.
Score: 0.053
-
Lack of effect of hot, humid air on response to nasal challenge with histamine. Ann Otol Rhinol Laryngol. 1996 Feb; 105(2):146-54.
Score: 0.033
-
Basophils and eosinophils in allergic rhinitis. J Allergy Clin Immunol. 1994 Dec; 94(6 Pt 2):1303-9.
Score: 0.031
-
The effect of terfenadine on unilateral nasal challenge with allergen. J Allergy Clin Immunol. 1994 Mar; 93(3):594-605.
Score: 0.029
-
Effect of oxymetazoline on the early response to nasal challenge with antigen. J Allergy Clin Immunol. 1993 Nov; 92(5):767-70.
Score: 0.028
-
Histamine-containing cells obtained from the nose hours after antigen challenge have functional and phenotypic characteristics of basophils. J Immunol. 1992 Apr 01; 148(7):2223-8.
Score: 0.025
-
Ketotifen reduces sneezing but not histamine release following nasal challenge with antigen. Clin Exp Allergy. 1990 Nov; 20(6):701-5.
Score: 0.023
-
Observations on the pathogenesis of nasal priming. J Allergy Clin Immunol. 1989 Oct; 84(4 Pt 1):492-501.
Score: 0.021
-
Nasal challenge with cold, dry air induces a late-phase reaction. Am Rev Respir Dis. 1988 Aug; 138(2):400-5.
Score: 0.020
-
In vivo release of inflammatory mediators by hyperosmolar solutions. Am Rev Respir Dis. 1988 Mar; 137(3):606-12.
Score: 0.019
-
Kinins are generated during experimental rhinovirus colds. J Infect Dis. 1988 Jan; 157(1):133-42.
Score: 0.019
-
Effect of short-term systemic glucocorticoid treatment on human nasal mediator release after antigen challenge. J Clin Invest. 1987 Oct; 80(4):957-61.
Score: 0.019
-
Studies of IgE-dependent histamine releasing factors: heterogeneity of IgE. J Immunol. 1987 Jul 15; 139(2):506-12.
Score: 0.018
-
Inhibition of mediator release in allergic rhinitis by pretreatment with topical glucocorticosteroids. N Engl J Med. 1987 Jun 11; 316(24):1506-10.
Score: 0.018
-
Demonstration of inhibition of mediator release from human mast cells by azatadine base. In vivo and in vitro evaluation. JAMA. 1986 Jan 10; 255(2):225-9.
Score: 0.017
-
Theophylline reduces the response to nasal challenge with antigen. Am J Med. 1985 Dec 20; 79(6A):43-7.
Score: 0.016
-
Inflammatory mediators and mechanisms of release from purified human basophils and mast cells. J Allergy Clin Immunol. 1984 Oct; 74(4 Pt 1):473-81.
Score: 0.015
-
Attenuation of allergen sensitivity early in the course of ragweed immunotherapy. J Allergy Clin Immunol. 1989 Sep; 84(3):390-9.
Score: 0.005
-
Leukotriene B4 as a mediator of early and late reactions to antigen in humans: the effect of systemic glucocorticoid treatment in vivo. J Allergy Clin Immunol. 1989 Mar; 83(3):634-42.
Score: 0.005
-
Basophil influx occurs after nasal antigen challenge: effects of topical corticosteroid pretreatment. J Allergy Clin Immunol. 1988 Mar; 81(3):580-9.
Score: 0.005
-
Kininogens in nasal secretions after allergen challenge. Adv Exp Med Biol. 1986; 198 Pt B:189-92.
Score: 0.004
-
Nasal challenge with ragweed pollen in hay fever patients. Effect of immunotherapy. J Clin Invest. 1985 Dec; 76(6):2247-53.
Score: 0.004
-
Nasal challenge with cold, dry air results in release of inflammatory mediators. Possible mast cell involvement. J Clin Invest. 1985 Oct; 76(4):1375-81.
Score: 0.004
-
Role of human basophils and mast cells in the pathogenesis of allergic diseases. J Allergy Clin Immunol. 1985 Aug; 76(2 Pt 2):369-74.
Score: 0.004
-
Mediator release after allergic and physical nasal challenges. Int Arch Allergy Appl Immunol. 1985; 77(1-2):57-63.
Score: 0.004